{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:14:59Z","timestamp":1790741699792,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s43440-023-00462-8","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T19:02:36Z","timestamp":1677697356000},"page":"442-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Design and optimization various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: potential anti-cancer effects against human lung cancer cells"],"prefix":"10.1007","volume":"75","author":[{"given":"Rasoul","family":"Shahbazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davoud","family":"Jafari-Gharabaghlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Mirjafary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Saeidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4236-4537","authenticated-orcid":false,"given":"Nosratollah","family":"Zarghami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"462_CR1","volume-title":"WHO report on cancer: setting priorities, investing wisely and providing care for all","author":"WH Organization","year":"2020","unstructured":"WH Organization. WHO report on cancer: setting priorities, investing wisely and providing care for all. Geneva: World Health Organization; 2020."},{"issue":"5","key":"462_CR2","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1021\/acsnano.9b09119","volume":"14","author":"H Shin","year":"2020","unstructured":"Shin H, Oh S, Hong S, Kang M, Kang D, Ji Y-g, et al. Early-stage lung cancer diagnosis by deep learning-based spectroscopic analysis of circulating exosomes. ACS Nano. 2020;14(5):5435\u201344.","journal-title":"ACS Nano"},{"key":"462_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10654-022-00877-2","volume":"37","author":"D Petrovic","year":"2022","unstructured":"Petrovic D, Bodinier B, Dagnino S, Whitaker M, Karimi M, Campanella G, et al. Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smoking. Eur J Epidemiol. 2022;37:1\u201312.","journal-title":"Eur J Epidemiol"},{"issue":"8","key":"462_CR4","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3390\/ijerph17082927","volume":"17","author":"VV Tran","year":"2020","unstructured":"Tran VV, Park D, Lee Y-C. Indoor air pollution, related human diseases, and recent trends in the control and improvement of indoor air quality. Int J Environ Health Res. 2020;17(8):2927.","journal-title":"Int J Environ Health Res"},{"issue":"2","key":"462_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/COC.0000000000000154","volume":"38","author":"H Willers","year":"2015","unstructured":"Willers H, Stinchcombe TE, Barriger RB, Chetty IJ, Ginsburg ME, Kestin LL, et al. ACR appropriateness criteria\u00ae induction and adjuvant therapy for N2 non\u2013small-cell lung cancer. Am J Clin Oncol. 2015;38(2):197\u2013205.","journal-title":"Am J Clin Oncol"},{"key":"462_CR6","unstructured":"Travis WD. Pathology & genetics tumours of the lung, pleura, thymus and heart. World Health Organization classification of tumours. 2004;10(3):341"},{"issue":"8","key":"462_CR7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.arcmed.2020.08.004","volume":"51","author":"DI Suster","year":"2020","unstructured":"Suster DI, Mino-Kenudson M. Molecular pathology of primary non-small cell lung cancer. Arch Med Res. 2020;51(8):784\u201398.","journal-title":"Arch Med Res"},{"issue":"1","key":"462_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1535-6108(02)00027-2","volume":"1","author":"JD Minna","year":"2002","unstructured":"Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell. 2002;1(1):49\u201352.","journal-title":"Cancer Cell"},{"issue":"4","key":"462_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00125480-199807000-00001","volume":"5","author":"TV Colby","year":"1998","unstructured":"Colby TV, Wistuba II, Gazdar A. Precursors to pulmonary neoplasia. Adv Anat Pathol. 1998;5(4):205\u201315.","journal-title":"Adv Anat Pathol"},{"issue":"8","key":"462_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2174\/1568009621666210525152802","volume":"21","author":"K Khazei","year":"2021","unstructured":"Khazei K, Mohajeri N, Bonabi E, Turk Z, Zarghami N. New insights toward nanostructured drug delivery of plant-derived polyphenol compounds: cancer treatment and gene expression profiles. Curr Cancer Drug Targets. 2021;21(8):689\u2013701.","journal-title":"Curr Cancer Drug Targets"},{"key":"462_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110975","volume":"133","author":"M Kong","year":"2021","unstructured":"Kong M, Xie K, Lv M, Li J, Yao J, Yan K, et al. Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise. Biomed Pharmacother. 2021;133: 110975.","journal-title":"Biomed Pharmacother"},{"key":"462_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s43440-021-00334-z","volume":"74","author":"M Khodadadi","year":"2022","unstructured":"Khodadadi M, Jafari-Gharabaghlou D, Zarghami N. An update on mode of action of metformin in modulation of meta-inflammation and inflammaging. Pharmacol Rep. 2022;74:310\u201322.","journal-title":"Pharmacol Rep"},{"key":"462_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12010-022-04000-9","volume":"194","author":"N Hassani","year":"2022","unstructured":"Hassani N, Jafari-Gharabaghlou D, Dadashpour M, Zarghami N. The effect of dual bioactive compounds artemisinin and metformin co-loaded in PLGA-PEG nano-particles on breast cancer cell lines: potential apoptotic and anti-proliferative action. Appl Biochem Biotechnol. 2022;194:1\u201316.","journal-title":"Appl Biochem Biotechnol"},{"issue":"11","key":"462_CR14","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.7314\/APJCP.2013.14.11.6949","volume":"14","author":"S Ghasemali","year":"2013","unstructured":"Ghasemali S, Nejati-Koshki K, Akbarzadeh A, Tafsiri E, Zarghami N, Rahmati-Yamchi M, et al. Inhibitory effects of \u03b2-cyclodextrin-helenalin complexes on H-TERT gene expression in the T47D breast cancer cell line-results of real time quantitative PCR. Asian Pac J Cancer Prev. 2013;14(11):6949\u201353.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"22","key":"462_CR15","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.2174\/0929867323666160425113705","volume":"23","author":"A Alibakhshi","year":"2016","unstructured":"Alibakhshi A, Ranjbari J, Pilehvar-Soltanahmadi Y, Nasiri M, Mollazade M, Zarghami N. An update on phytochemicals in molecular target therapy of cancer: potential inhibitory effect on telomerase activity. Curr Med Chem. 2016;23(22):2380\u201393.","journal-title":"Curr Med Chem"},{"key":"462_CR16","doi-asserted-by":"publisher","DOI":"10.17795\/ijcp-4190","author":"F Mohammadian","year":"2016","unstructured":"Mohammadian F, Abhari A, Dariushnejad H, Nikanfar A, Pilehvar-Soltanahmadi Y, Zarghami N. Effects of chrysin-PLGA-PEG nanoparticles on proliferation and gene expression of miRNAs in gastric cancer cell line. Iran J Cancer Prev. 2016. https:\/\/doi.org\/10.17795\/ijcp-4190.","journal-title":"Iran J Cancer Prev"},{"issue":"sup2","key":"462_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/21691401.2018.1452021","volume":"46","author":"F Tavakoli","year":"2018","unstructured":"Tavakoli F, Jahanban-Esfahlan R, Seidi K, Jabbari M, Behzadi R, Pilehvar-Soltanahmadi Y, et al. Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model. Artif Cells Nanomed Biotechnol. 2018;46(sup2):75\u201386.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"11","key":"462_CR18","first-page":"5995","volume":"37","author":"S Slez\u00e1kov\u00e1","year":"2017","unstructured":"Slez\u00e1kov\u00e1 S, Ruda-Kucerova J. Anticancer activity of artemisinin and its derivatives. Anticancer res. 2017;37(11):5995\u20136003.","journal-title":"Anticancer res"},{"issue":"11","key":"462_CR19","first-page":"1167","volume":"21","author":"D Jafari-Gharabaghlou","year":"2018","unstructured":"Jafari-Gharabaghlou D, Pilehvar-Soltanahmadi Y, Dadashpour M, Mota A, Vafajouy-Jamshidi S, Faramarzi L, et al. Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells. Iran J Basic Med Sci. 2018;21(11):1167.","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"462_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.31557\/APJCP.2022.23.2.519","volume":"23","author":"E Salmani Javan","year":"2022","unstructured":"Salmani Javan E, Lotfi F, Jafari-Gharabaghlou D, Mousazadeh H, Dadashpour M, Zarghami N. Development of a magnetic nanostructure for co-delivery of metformin and silibinin on growth of lung cancer cells: Possible action through leptin gene and its receptor regulation. Asian Pac J Cancer Prev. 2022;23(2):519\u201327.","journal-title":"Asian Pac J Cancer Prev"},{"key":"462_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103389","volume":"73","author":"Y Alagheband","year":"2022","unstructured":"Alagheband Y, Jafari-gharabaghlou D, Imani M, Mousazadeh H, Dadashpour M, Firouzi-Amandi A, et al. Design and fabrication of a dual-drug loaded nano-platform for synergistic anticancer and cytotoxicity effects on the expression of leptin in lung cancer treatment. J Drug Deliv Sci Technol. 2022;73: 103389.","journal-title":"J Drug Deliv Sci Technol"},{"key":"462_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jddst.2017.09.013","volume":"43","author":"S Javidfar","year":"2018","unstructured":"Javidfar S, Pilehvar-Soltanahmadi Y, Farajzadeh R, Lotfi-Attari J, Shafiei-Irannejad V, Hashemi M, et al. The inhibitory effects of nano-encapsulated metformin on growth and hTERT expression in breast cancer cells. J Drug Deliv Sci Technol. 2018;43:19\u201326.","journal-title":"J Drug Deliv Sci Technol"},{"key":"462_CR23","volume-title":"Metformin activity against breast cancer: mechanistic differences by molecular subtype and metabolic conditions","author":"RS Wahdan-Alaswad","year":"2020","unstructured":"Wahdan-Alaswad RS, Thor AD. Metformin activity against breast cancer: mechanistic differences by molecular subtype and metabolic conditions. London: IntechOpen; 2020."},{"issue":"1","key":"462_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4161\/cc.8.1.7499","volume":"8","author":"A Vazquez-Martin","year":"2009","unstructured":"Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells. Cell Cycle. 2009;8(1):88\u201396.","journal-title":"Cell Cycle"},{"key":"462_CR25","doi-asserted-by":"publisher","first-page":"6593","DOI":"10.2147\/IJN.S323831","volume":"16","author":"S Milewska","year":"2021","unstructured":"Milewska S, Niemirowicz-Laskowska K, Siemiaszko G, Nowicki P, Wilczewska AZ, Car H. Current trends and challenges in pharmacoeconomic aspects of nanocarriers as drug delivery systems for cancer treatment. Int J Nanomed. 2021;16:6593.","journal-title":"Int J Nanomed"},{"issue":"08","key":"462_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1055\/s-0043-125314","volume":"68","author":"R Zamani","year":"2018","unstructured":"Zamani R, Aval SF, Pilehvar-Soltanahmadi Y, Nejati-Koshki K, Zarghami N. Recent advances in cell electrospining of natural and synthetic nanofibers for regenerative medicine. Drug res. 2018;68(08):425\u201335.","journal-title":"Drug res"},{"issue":"3","key":"462_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1021\/acsabm.2c00002","volume":"5","author":"MI Khan","year":"2022","unstructured":"Khan MI, Hossain MI, Hossain MK, Rubel M, Hossain K, Mahfuz A, et al. Recent progress in nanostructured smart drug delivery systems for cancer therapy: a review. ACS Appl Bio Mater. 2022;5(3):971\u20131012.","journal-title":"ACS Appl Bio Mater"},{"key":"462_CR28","doi-asserted-by":"publisher","first-page":"105019","DOI":"10.1016\/j.chemphyslip.2020.105019","volume":"234","author":"I Akbarzadeh","year":"2021","unstructured":"Akbarzadeh I, Keramati M, Azadi A, Afzali E, Shahbazi R, Norouzian D, et al. Optimization, physicochemical characterization, and antimicrobial activity of a novel simvastatin nano-niosomal gel against E. coli and S. aureus. Chem Phys Lipids. 2021;234:105019.","journal-title":"Chem Phys Lipids"},{"issue":"9","key":"462_CR29","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1080\/03639045.2020.1810269","volume":"46","author":"I Akbarzadeh","year":"2020","unstructured":"Akbarzadeh I, Saremi Poor A, Yaghmaei S, Norouzian D, Noorbazargan H, Saffar S, et al. Niosomal delivery of simvastatin to MDA-MB-231 cancer cells. Drug Dev Ind Pharm. 2020;46(9):1535\u201349.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1\u20132","key":"462_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ijpharm.2010.03.064","volume":"392","author":"A Manosroi","year":"2010","unstructured":"Manosroi A, Khanrin P, Lohcharoenkal W, Werner RG, G\u00f6tz F, Manosroi W, et al. Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm. 2010;392(1\u20132):304\u201310.","journal-title":"Int J Pharm"},{"issue":"9","key":"462_CR31","first-page":"567","volume":"6","author":"OA Mohawed","year":"2014","unstructured":"Mohawed OA, El-Ashmoony M, Elgazayerly ON. Niosome-encapsulated clomipramine for transdermal controlled delivery. Int J Pharm Pharm Sci. 2014;6(9):567\u201375.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"2","key":"462_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/BJPR\/2016\/26985","volume":"12","author":"A Usama","year":"2016","unstructured":"Usama A, Fetih G, El-Faham T. Performance of meloxicam niosomal gel formulations for transdermal drug delivery. Br J Pharm Res. 2016;12(2):1\u201314.","journal-title":"Br J Pharm Res"},{"issue":"5","key":"462_CR33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/01932690701751801","volume":"29","author":"A Azeem","year":"2008","unstructured":"Azeem A, Ahmad FJ, Khan ZI, Talegaonkar S. Nonionic surfactant vesicles as a carrier for transdermal delivery of frusemide. J Dispers Sci Technol. 2008;29(5):723\u201330.","journal-title":"J Dispers Sci Technol"},{"issue":"1\u20132","key":"462_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijpharm.2012.05.011","volume":"433","author":"H Abdelkader","year":"2012","unstructured":"Abdelkader H, Wu Z, Al-Kassas R, Alany RG. Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. Int J Pharm. 2012;433(1\u20132):142\u20138.","journal-title":"Int J Pharm"},{"key":"462_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.colsurfb.2016.01.014","volume":"141","author":"W Zeng","year":"2016","unstructured":"Zeng W, Li Q, Wan T, Liu C, Pan W, Wu Z, et al. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Coll Surf B Biointerfaces. 2016;141:28\u201335.","journal-title":"Coll Surf B Biointerfaces"},{"issue":"4","key":"462_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4103\/0975-7406.120080","volume":"5","author":"S Bansal","year":"2013","unstructured":"Bansal S, Aggarwal G, Chandel P, Harikumar S. Design and development of cefdinir niosomes for oral delivery. J Pharm Bioallied Sci. 2013;5(4):318.","journal-title":"J Pharm Bioallied Sci"},{"issue":"3","key":"462_CR37","first-page":"147","volume":"4","author":"K Bini","year":"2012","unstructured":"Bini K, Akhilesh D, Prabhakara P, Kamath J. Development and characterization of non-ionic surfactant vesicles (niosomes) for oral delivery of lornoxicam. Int J Drug Dev Res. 2012;4(3):147\u201354.","journal-title":"Int J Drug Dev Res"},{"issue":"1","key":"462_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jconrel.2010.06.022","volume":"147","author":"C Marianecci","year":"2010","unstructured":"Marianecci C, Paolino D, Celia C, Fresta M, Carafa M, Alhaique F. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. J Control Release. 2010;147(1):127\u201335.","journal-title":"J Control Release"},{"key":"462_CR39","doi-asserted-by":"publisher","first-page":"184954351880535","DOI":"10.1177\/1849543518805355","volume":"5","author":"A De","year":"2018","unstructured":"De A, Venkatesh N, Senthil M, Sanapalli BKR, Shanmugham R, Karri VVSR. Smart niosomes of temozolomide for enhancement of brain targeting. Nanobiomedicine. 2018;5:1849543518805355.","journal-title":"Nanobiomedicine"},{"issue":"2","key":"462_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/10717544.2013.838077","volume":"21","author":"H Abdelkader","year":"2014","unstructured":"Abdelkader H, Alani AW, Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug deliv. 2014;21(2):87\u2013100.","journal-title":"Drug deliv"},{"issue":"4","key":"462_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.2042-7158.1985.tb05051.x","volume":"37","author":"M Azmin","year":"1985","unstructured":"Azmin M, Florence A, Handjani-Vila R, Stuart J, Vanlerberghe G, Whittaker J. The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J Pharm Pharmacol. 1985;37(4):237\u201342.","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"462_CR42","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4103\/0250-474X.29622","volume":"68","author":"C Jain","year":"2006","unstructured":"Jain C, Vyas S, Dixit V. Niosomal system for delivery of rifampicin to lymphatics. Indian J Pharm Sci. 2006;68(5):575.","journal-title":"Indian J Pharm Sci"},{"issue":"6","key":"462_CR43","first-page":"1972","volume":"23","author":"MJ Ansari","year":"2016","unstructured":"Ansari MJ, Anwer MK, Jamil S, Al-Shdefat R, Ali BE, Ahmad MM, et al. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats. Drug Deliv. 2016;23(6):1972\u20139.","journal-title":"Drug Deliv"},{"key":"462_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118580","volume":"569","author":"R Ghafelehbashi","year":"2019","unstructured":"Ghafelehbashi R, Akbarzadeh I, Yaraki MT, Lajevardi A, Fatemizadeh M, Saremi LH. Preparation, physicochemical properties, in vitro evaluation and release behavior of cephalexin-loaded niosomes. Int J Pharm. 2019;569: 118580.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"462_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpharm.2005.05.009","volume":"300","author":"B Nasseri","year":"2005","unstructured":"Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm. 2005;300(1\u20132):95\u2013101.","journal-title":"Int J Pharm"},{"issue":"1","key":"462_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.colsurfb.2011.05.018","volume":"87","author":"SK Mehta","year":"2011","unstructured":"Mehta SK, Jindal N, Kaur G. Quantitative investigation, stability and in vitro release studies of anti-TB drugs in triton niosomes. Coll Surf B Biointerfaces. 2011;87(1):173\u20139.","journal-title":"Coll Surf B Biointerfaces"},{"issue":"1","key":"462_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/cbdd.13078","volume":"91","author":"V Shafiei-Irannejad","year":"2018","unstructured":"Shafiei-Irannejad V, Samadi N, Yousefi B, Salehi R, Velaei K, Zarghami N. Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P-gp-overexpressing MCF-7 cells. Chem Biol Drug Des. 2018;91(1):269\u201376.","journal-title":"Chem Biol Drug Des"},{"key":"462_CR48","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.biopha.2016.10.095","volume":"84","author":"A Eatemadi","year":"2016","unstructured":"Eatemadi A, Daraee H, Aiyelabegan HT, Negahdari B, Rajeian B, Zarghami N. Synthesis and characterization of chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line. Biomed Pharmacother. 2016;84:1915\u201322.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"462_CR49","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2174\/1871520617666170213115756","volume":"17","author":"H Sadeghzadeh","year":"2017","unstructured":"Sadeghzadeh H, Pilehvar-Soltanahmadi Y, Akbarzadeh A, Dariushnejad H, Sanjarian F, Zarghami N. The effects of nanoencapsulated curcumin-Fe3O4 on proliferation and hTERT gene expression in lung cancer cells. Anti-Cancer Agents Med Chem. 2017;17(10):1363\u201373.","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"462_CR50","first-page":"23","volume":"4","author":"R Muzzalupo","year":"2015","unstructured":"Muzzalupo R, Tavano L. Niosomal drug delivery for transdermal targeting: recent advances. Res Rep Transdermal Drug Deliv. 2015;4:23\u201333.","journal-title":"Res Rep Transdermal Drug Deliv"},{"issue":"5","key":"462_CR51","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/1567201812666150511095432","volume":"12","author":"R Rochdy Haj-Ahmad","year":"2015","unstructured":"Rochdy Haj-Ahmad R, Ali Elkordy A, Shu CC. In vitro characterisation of span\u2122 65 niosomal formulations containing proteins. Curr Drug Deliv. 2015;12(5):628\u201339.","journal-title":"Curr Drug Deliv"},{"issue":"5","key":"462_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40005-014-0121-8","volume":"44","author":"H Abdelkader","year":"2014","unstructured":"Abdelkader H, Farghaly U, Moharram H. Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug. J Pharm Investig. 2014;44(5):329\u201337.","journal-title":"J Pharm Investig"},{"issue":"5","key":"462_CR53","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/jps.22422","volume":"100","author":"H Abdelkader","year":"2011","unstructured":"Abdelkader H, Ismail S, Kamal A, Alany RG. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci. 2011;100(5):1833\u201346.","journal-title":"J Pharm Sci"},{"key":"462_CR54","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejps.2014.05.020","volume":"62","author":"Q Li","year":"2014","unstructured":"Li Q, Li Z, Zeng W, Ge S, Lu H, Wu C, et al. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Eur J Pharm Sci. 2014;62:115\u201323.","journal-title":"Eur J Pharm Sci"},{"key":"462_CR55","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.foodchem.2016.11.129","volume":"221","author":"L Basiri","year":"2017","unstructured":"Basiri L, Rajabzadeh G, Bostan A. \u03b1-Tocopherol-loaded niosome prepared by heating method and its release behavior. Food chem. 2017;221:620\u20138.","journal-title":"Food chem"},{"issue":"1\u20132","key":"462_CR56","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ijpharm.2015.07.041","volume":"493","author":"DS Shaker","year":"2015","unstructured":"Shaker DS, Shaker MA, Hanafy MS. Cellular uptake, cytotoxicity and in-vivo evaluation of tamoxifen citrate loaded niosomes. Int J Pharm. 2015;493(1\u20132):285\u201394.","journal-title":"Int J Pharm"},{"issue":"1","key":"462_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.xphs.2016.07.007","volume":"106","author":"MA Kassem","year":"2017","unstructured":"Kassem MA, El-Sawy HS, Abd-Allah FI, Abdelghany TM, Khalid M. Maximizing the therapeutic efficacy of imatinib mesylate\u2013loaded niosomes on human colon adenocarcinoma using Box-Behnken design. J Pharm Sci. 2017;106(1):111\u201322.","journal-title":"J Pharm Sci"},{"issue":"2","key":"462_CR58","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.imr.2014.10.004","volume":"4","author":"J Patel","year":"2015","unstructured":"Patel J, Ketkar S, Patil S, Fearnley J, Mahadik KR, Paradkar AR. Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration. Integr Med Res. 2015;4(2):94\u2013101.","journal-title":"Integr Med Res"},{"issue":"1","key":"462_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejpb.2014.01.006","volume":"87","author":"M Bragagni","year":"2014","unstructured":"Bragagni M, Mennini N, Furlanetto S, Orlandini S, Ghelardini C, Mura P. Development and characterization of functionalized niosomes for brain targeting of dynorphin-B. Eur J Pharm Biopharm. 2014;87(1):73\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"462_CR60","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.015","volume":"185","author":"S Moghassemi","year":"2014","unstructured":"Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22\u201336.","journal-title":"J Control Release"},{"issue":"2","key":"462_CR61","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jconrel.2005.06.015","volume":"107","author":"GA Husseini","year":"2005","unstructured":"Husseini GA, De La Rosa MAD, Richardson ES, Christensen DA, Pitt WG. The role of cavitation in acoustically activated drug delivery. J Control Release. 2005;107(2):253\u201361.","journal-title":"J Control Release"},{"issue":"4","key":"462_CR62","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/drd_10_4_251","volume":"10","author":"J Varshosaz","year":"2003","unstructured":"Varshosaz J, Pardakhty A, Hajhashemi V-i, Najafabadi AR. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv. 2003;10(4):251\u201362.","journal-title":"Drug Deliv"},{"issue":"7","key":"462_CR63","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3109\/02652048.2010.506579","volume":"27","author":"E Moazeni","year":"2010","unstructured":"Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, et al. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery. J Microencapsul. 2010;27(7):618\u201327.","journal-title":"J Microencapsul"},{"issue":"5","key":"462_CR64","first-page":"1757","volume":"4","author":"A Marwa","year":"2013","unstructured":"Marwa A, Omaima S, Hanaa E-G, Mohammed A-S. Preparation and in-vitro evaluation of diclofenac sodium niosomal formulations. Int J Pharm Sci Res. 2013;4(5):1757.","journal-title":"Int J Pharm Sci Res"},{"issue":"12","key":"462_CR65","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1529\/biophysj.107.104042","volume":"93","author":"ES Richardson","year":"2007","unstructured":"Richardson ES, Pitt WG, Woodbury DJ. The role of cavitation in liposome formation. Biophys J. 2007;93(12):4100\u20137.","journal-title":"Biophys J"},{"issue":"3\u20134","key":"462_CR66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/08982100500364131","volume":"15","author":"S-C Lee","year":"2005","unstructured":"Lee S-C, Lee K-E, Kim J-J, Lim S-H. The effect of cholesterol in the liposome bilayer on the stabilization of incorporated retinol. J Liposome Res. 2005;15(3\u20134):157\u201366.","journal-title":"J Liposome Res"},{"key":"462_CR67","unstructured":"Cable C. An examination of the effect of surface modifications on the physicochemical and biological properties of non-ionic surfactant vesicles (surfactant vesicles, physicochemical properties), in Ph. D. Thesis 1989. Strathclyde: Glasgow"},{"key":"462_CR68","first-page":"301","volume-title":"Liposomes: a practical approach: edited by RRC New","author":"H Patel","year":"1990","unstructured":"Patel H. Liposomes: a practical approach: edited by RRC New. Oxford: Oxford University Press; 1990. p. 301 (\u00a3 22.50. No longer published by Elsevier; 1990)."},{"issue":"6","key":"462_CR69","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3109\/10731199.2011.611476","volume":"39","author":"M Gupta","year":"2011","unstructured":"Gupta M, Vaidya B, Mishra N, Vyas SP. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery. Artif Cells Blood Substit Immobil Biotechnol. 2011;39(6):376\u201384.","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"issue":"1\u20132","key":"462_CR70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0378-5173(98)00169-0","volume":"172","author":"IF Uchegbu","year":"1998","unstructured":"Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172(1\u20132):33\u201370.","journal-title":"Int J Pharm"},{"issue":"7","key":"462_CR71","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/10717540701603597","volume":"14","author":"P Khazaeli","year":"2007","unstructured":"Khazaeli P, Pardakhty A, Shoorabi H. Caffeine-loaded niosomes: characterization and in vitro release studies. Drug deliv. 2007;14(7):447\u201352.","journal-title":"Drug deliv"},{"key":"462_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-5173(94)90228-3","volume":"105","author":"T Yoshioka","year":"1994","unstructured":"Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm. 1994;105:1.","journal-title":"Int J Pharm"},{"key":"462_CR73","doi-asserted-by":"publisher","first-page":"9777","DOI":"10.2147\/IJN.S230269","volume":"14","author":"S Sadeghi","year":"2019","unstructured":"Sadeghi S, Bakhshandeh H, Cohan RA, Peirovi A, Ehsani P, Norouzian D. Synergistic anti-staphylococcal activity of niosomal recombinant lysostaphin-LL-37. Int J Nanomed. 2019;14:9777.","journal-title":"Int J Nanomed"},{"issue":"1","key":"462_CR74","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40199-018-0207-3","volume":"26","author":"M Barani","year":"2018","unstructured":"Barani M, Mirzaei M, Torkzadeh-Mahani M, Nematollahi MH. Lawsone-loaded niosome and its antitumor activity in MCF-7 breast cancer cell line: a nano-herbal treatment for cancer. DARU J Pharm Sci. 2018;26(1):11\u20137.","journal-title":"DARU J Pharm Sci"},{"issue":"5","key":"462_CR75","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4103\/1735-5362.268206","volume":"14","author":"MR Hajizadeh","year":"2019","unstructured":"Hajizadeh MR, Maleki H, Barani M, Fahmidehkar MA, Mahmoodi M, Torkzadeh-Mahani M. In vitro cytotoxicity assay of D-limonene niosomes: an efficient nano-carrier for enhancing solubility of plant-extracted agents. Res Pharm Sci. 2019;14(5):448.","journal-title":"Res Pharm Sci"},{"issue":"1\u20132","key":"462_CR76","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0378-5173(02)00301-0","volume":"244","author":"Y Hao","year":"2002","unstructured":"Hao Y, Zhao F, Li N, Yang Y. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002;244(1\u20132):73\u201380.","journal-title":"Int J Pharm"},{"issue":"6","key":"462_CR77","first-page":"404","volume":"19","author":"A Pardakhty","year":"2011","unstructured":"Pardakhty A, Moazeni E, Varshosaz J, Hajhashemi V, Najafabadi AR. Pharmacokinetic study of niosome-loaded insulin in diabetic rats. DARU J Pharm Sci. 2011;19(6):404.","journal-title":"DARU J Pharm Sci"},{"key":"462_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101715","volume":"57","author":"I Akbarzadeh","year":"2020","unstructured":"Akbarzadeh I, Yaraki MT, Bourbour M, Noorbazargan H, Lajevardi A, Shilsar SMS, et al. Optimized doxycycline-loaded niosomal formulation for treatment of infection-associated prostate cancer: an in-vitro investigation. J Drug Deliv Sci Technol. 2020;57: 101715.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"462_CR79","first-page":"12","volume":"6","author":"M Seras-Cansell","year":"1996","unstructured":"Seras-Cansell M, Ollivon M, Lesieur S. Generation of non-ionic monoalkyl amphiphile-cholesterol vesicles: evidence of membrane impermeability to octyl glucoside. STP Pharma Sci. 1996;6(1):12\u201320.","journal-title":"STP Pharma Sci"},{"issue":"5","key":"462_CR80","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3892\/ol.2012.834","volume":"4","author":"O Yoon","year":"2012","unstructured":"Yoon O, Roh J. Downregulation of KLF4 and the Bcl-2\/Bax ratio in advanced epithelial ovarian cancer. Oncol Lett. 2012;4(5):1033\u20136.","journal-title":"Oncol Lett"},{"issue":"7","key":"462_CR81","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.sjbs.2018.04.003","volume":"25","author":"J Chen","year":"2018","unstructured":"Chen J, Zhang L, Hao M. Effect of artemisinin on proliferation and apoptosis-related protein expression in vivo and in vitro. Saudi J Biol Sci. 2018;25(7):1488\u201393.","journal-title":"Saudi J Biol Sci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00462-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-023-00462-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00462-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T13:06:11Z","timestamp":1680181571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-023-00462-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["462"],"URL":"https:\/\/doi.org\/10.1007\/s43440-023-00462-8","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"24 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}